August 4, 2020
Dr. Mel Spigelman Named in Fast Company’s Annual List of the Most Creative People in Business
August 3, 2020
TB Alliance Announces European Commission Authorisation of New Treatment for Highly Drug-Resistant Tuberculosis
Pretomanid, developed by the non-profit TB Alliance, has received EU marketing authorisation in combination regimen with bedaquiline and linezolid in adults with XDR-TB or treatment-intolerant/non-responsive MDR-TB July 22, 2020
Global Health Leaders Chart the Path Forward in Pandemic Response
Dr. Anthony Fauci Calls for a Unified Approach and Continuous Commitment to Pandemic Preparedness July 22, 2020
Mylan Secures DCGI Approval in India for Pretomanid, a Treatment for Highly Drug-Resistant Forms of Tuberculosis
June 18, 2020
New Report Highlights Urgent Need for Improved Treatments for Children with MDR-TB
Tuberculosis is a leading cause of death worldwide. Children with drug-resistant TB need improved treatment options June 5, 2020
Standing Against Racism and Injustice
A Message to the TB Alliance Family June 2, 2020
InveniAI Announces Strategic Partnership with TB Alliance to Advance the Development of Transformative Therapies for Tuberculosis
TB Alliance to leverage AlphaMeld, an AI-powered platform to capture and accelerate innovation to address unmet needs May 28, 2020